20/07 Pareto Securities raises C-Rad price target to 45 kronor (36), reiterates buy FW
17/07 C-Rad AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
17/07 C-Rad increased revenue and improved operating profit FW
17/07 C RAD : Interim Report Q2'26 PU
17/07 C-RAD's Interim Report Q2’26 AQ
17/06 C-Rad executive purchases shares worth nearly SEK 0.4m FW
15/06 C-Rad COO Johan Danielsson purchases shares worth SEK 0.25m FW
10/06 C-Rad CFO Linda Frölén buys shares worth SEK 0.75 million FW
15/05 C-Rad and SeeTreat launch partnership for personalized radiotherapy FW
15/05 C-Rad, SeeTreat partner to deliver radiotherapy RE
15/05 C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient AQ
15/05 C-Rad and Seetreat Partner to Deliver Personalised Radiotherapy for Every Patient CI
13/05 C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances AQ
07/05 Pareto Securities raises C-Rad price target to SEK 36 (30), reiterates Buy FW
06/05 Affärsvärlden issues buy rating for C-Rad FW
06/05 C-Rad AB Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
06/05 C Rad Q1 adjusted EBIT SEK 22 mln RE
06/05 C-Rad reports revenue decline but posts higher operating profit FW
06/05 C-RAD's Interim Report Q1’26 AQ
28/04 Pareto Securities cuts C-Rad price target to SEK 30 (35), reiterates Buy FW
10/04 C-RAD publishes its annual report for 2025 AQ
01/04 C-Rad proposes Thomas Axelsson as new Chairman FW
05/03 Linc Increases Stake to Over 10 Percent in C-Rad FW
13/02 Pareto Securities Lowers Price Target for C-Rad to 35 Kronor (38), Reiterates Buy FW
13/02 C-Rad AB, 2025 Earnings Call, Feb 12, 2026
No results match your criteria